BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21060273)

  • 1. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Lee BJ; Yu HG
    Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.
    Lee JY; Jeong HS; Lee DY; Sohn HJ; Nam DH
    Retina; 2012 Oct; 32(9):1767-74. PubMed ID: 22481480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes between 23-gauge and 20-gauge vitrectomy in patients with proliferative diabetic retinopathy.
    Park DH; Shin JP; Kim SY
    Retina; 2010; 30(10):1662-70. PubMed ID: 20661174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transconjunctival 20-gauge vitrectomy: a pilot study.
    Aguni JS; Meyer CH; Rodrigues EB
    Ophthalmologica; 2009; 223(1):12-6. PubMed ID: 18849631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy.
    Woo SJ; Park KH; Hwang JM; Kim JH; Yu YS; Chung H
    Retina; 2009 Apr; 29(4):456-63. PubMed ID: 19174725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.
    Ibarra MS; Hermel M; Prenner JL; Hassan TS
    Am J Ophthalmol; 2005 May; 139(5):831-6. PubMed ID: 15860288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective comparison of 25-gauge transconjunctival sutureless vitrectomy to 20-gauge vitrectomy for the repair of pseudophakic primary inferior rhegmatogenous retinal detachment.
    Colyer MH; Barazi MK; von Fricken MA
    Retina; 2010; 30(10):1678-84. PubMed ID: 20838361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy.
    Tewari A; Shah GK; Fang A
    Retina; 2008 Feb; 28(2):258-62. PubMed ID: 18301031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions.
    Acar N; Kapran Z; Unver YB; Altan T; Ozdogan S
    Retina; 2008 Apr; 28(4):545-52. PubMed ID: 18398355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive use of a novel releasable suture technique in transconjunctival vitrectomy.
    Song Y; Shin YW; Lee BR
    Retina; 2011 Feb; 31(2):243-9. PubMed ID: 20966824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
    Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
    Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term outcome of bimanual 23-gauge transconjunctival sutureless vitrectomy for patients with complicated vitreoretinopathies.
    Park KH; Woo SJ; Hwang JM; Kim JH; Yu YS; Chung H
    Ophthalmic Surg Lasers Imaging; 2010; 41(2):207-14. PubMed ID: 20307039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25-Gauge sutureless vitrectomy versus 20-gauge vitrectomy for the repair of primary rhegmatogenous retinal detachment.
    Von Fricken MA; Kunjukunju N; Weber C; Ko G
    Retina; 2009 Apr; 29(4):444-50. PubMed ID: 19174723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy].
    Messmer E; Bornfeld N; Oehlschläger U; Heinrich T; Foerster MH; Wessing A
    Klin Monbl Augenheilkd; 1992 Apr; 200(4):267-72. PubMed ID: 1614088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
    Ulbig M; Kampik A; Heidenkummer HP
    Fortschr Ophthalmol; 1990; 87(5):443-8. PubMed ID: 2272571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.